Analyst Consensus ?
ConsensusBuy21 ratings
Bullish1990.5%
Neutral14.8%
Bearish14.7%
FN2 Earnings Intelligence
Vertiv Holdings Co complete analyst coverage
Vertiv Holdings Co (VRT) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$242.94Current
$18Low
$298.43Average
$500High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Outperform | Outperform | Maintain | Oct 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 12, 2026 |
| GLJ Research | Sell | Sell | Maintain | Oct 9, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 21, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 20, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 15, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 15, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 24, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 23, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 14, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 9, 2025 |
| UBS | Buy | Buy | Maintain | Oct 23, 2025 |
| Roth Capital | Buy | Buy | Maintain | Oct 21, 2025 |
| Melius Research | Buy | Hold | Upgrade | Jul 8, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 14, 2023 |
| Vertical Research | Buy | Hold | Upgrade | Jun 9, 2023 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Oct 27, 2022 |
| Guggenheim | Buy | Buy | Maintain | Nov 12, 2020 |
Named analyst price targets
Upside is calculated against the persisted current price $242.94. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $330 | $209.56 | +35.8% | Oct 16, 2026 |
| BMO Capital | Analyst unavailable | $329 | $252.18 | +35.4% | Oct 4, 2026 |
| Wells Fargo | Stephen Tusa | $340 | $245.3 | +40.0% | Sep 24, 2026 |
| GLJ Research | Analyst unavailable | $381 | $275.17 | +56.8% | Aug 7, 2026 |
| Bernstein | Varun Govindaraj | $368 | $242.93 | +51.5% | Jul 31, 2026 |
| UBS | Amit Mehrotra | $370 | $228.56 | +52.3% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $320 | $233.42 | +31.7% | Jul 30, 2026 |
| RBC Capital | Analyst unavailable | $337 | $237.54 | +38.7% | Jul 30, 2026 |
| Oppenheimer | Noah Kaye | $325 | $237.53 | +33.8% | Jul 30, 2026 |
| Evercore ISI | Analyst unavailable | $375 | $228.96 | +54.4% | Jul 29, 2026 |
| Piper Sandler | Analyst unavailable | $375 | $233.92 | +54.4% | Jul 29, 2026 |
| KeyBanc | Analyst unavailable | $360 | $301.16 | +48.2% | Jul 23, 2026 |
| RBC Capital | Analyst unavailable | $418 | $294 | +72.1% | Jul 16, 2026 |
| Robert W. Baird | Luke Junk | $370 | $304.57 | +52.3% | Jul 15, 2026 |
| Bernstein | Analyst unavailable | $416 | $289.52 | +71.2% | Jun 9, 2026 |
| Roth Capital | Justin Clare | $355 | $328.36 | +46.1% | May 21, 2026 |
| Oppenheimer | Noah Kaye | $353 | $315.67 | +45.3% | May 21, 2026 |
| Mizuho Securities | Brett Linzey | $380 | $315.67 | +56.4% | May 21, 2026 |
| RBC Capital | Deane Dray | $435 | $364.5 | +79.1% | May 15, 2026 |
| Barclays | Analyst unavailable | $412 | $376.23 | +69.6% | May 15, 2026 |
| Loop Capital Markets | Analyst unavailable | $500 | $376.23 | +105.8% | May 14, 2026 |
| Evercore ISI | Analyst unavailable | $425 | $357.43 | +74.9% | May 12, 2026 |
| Morgan Stanley | Analyst unavailable | $350 | $323.7 | +44.1% | Apr 23, 2026 |
| Oppenheimer | Analyst unavailable | $330 | $323.86 | +35.8% | Apr 23, 2026 |
| Cowen & Co. | Analyst unavailable | $347 | $316.09 | +42.8% | Apr 23, 2026 |
| RBC Capital | Analyst unavailable | $356 | $317 | +46.5% | Apr 23, 2026 |
| Barclays | Analyst unavailable | $345 | $305.14 | +42.0% | Apr 23, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $308.21 | +44.1% | Apr 20, 2026 |
| Roth Capital | Analyst unavailable | $335 | $301.16 | +37.9% | Apr 16, 2026 |
| BNP Paribas | Analyst unavailable | $345 | $299.96 | +42.0% | Apr 14, 2026 |
| Morgan Stanley | Analyst unavailable | $285 | $238.08 | +17.3% | Feb 13, 2026 |
| Oppenheimer | Analyst unavailable | $270 | $253.99 | +11.1% | Feb 12, 2026 |
| Goldman Sachs | Mark Delaney | $277 | $252.86 | +14.0% | Feb 12, 2026 |
| Barclays | Julian Mitchell | $281 | $252.69 | +15.7% | Feb 12, 2026 |
| RBC Capital | Deane Dray | $266 | $251.72 | +9.5% | Feb 12, 2026 |
| Roth Capital | Analyst unavailable | $275 | $248.51 | +13.2% | Feb 12, 2026 |
| Mizuho Securities | Brett Linzey | $290 | $248.51 | +19.4% | Feb 12, 2026 |
| Deutsche Bank | Analyst unavailable | $281 | $248.51 | +15.7% | Feb 12, 2026 |
| Evercore ISI | Analyst unavailable | $280 | $245.22 | +15.3% | Feb 11, 2026 |
| RBC Capital | Analyst unavailable | $200 | $176.96 | -17.7% | Jan 15, 2026 |
| Barclays | Julian Mitchell | $200 | $162.01 | -17.7% | Jan 2, 2026 |
| Goldman Sachs | Analyst unavailable | $204 | $185.61 | -16.0% | Dec 9, 2025 |
| Barclays | Analyst unavailable | $181 | $178.88 | -25.5% | Dec 4, 2025 |
| Cowen & Co. | Michael Elias | $211 | $177.86 | -13.1% | Dec 1, 2025 |
| Cowen & Co. | Michael Elias | $210 | $183.43 | -13.6% | Oct 23, 2025 |
| RBC Capital | Analyst unavailable | $196 | $180.95 | -19.3% | Oct 23, 2025 |
| UBS | Analyst unavailable | $201 | $171.59 | -17.3% | Oct 23, 2025 |
| Oppenheimer | Analyst unavailable | $195 | $171.59 | -19.7% | Oct 23, 2025 |
| Morgan Stanley | Christopher Snyder | $200 | $180.74 | -17.7% | Oct 23, 2025 |
| Goldman Sachs | Analyst unavailable | $182 | $171.59 | -25.1% | Oct 23, 2025 |
| Barclays | Analyst unavailable | $170 | $171.59 | -30.0% | Oct 23, 2025 |
| Roth Capital | Analyst unavailable | $195 | $175.73 | -19.7% | Oct 21, 2025 |
| Mizuho Securities | Analyst unavailable | $198 | $177.82 | -18.5% | Oct 17, 2025 |
| Deutsche Bank | Nicole Deblase | $216 | $175.15 | -11.1% | Oct 15, 2025 |
| Oppenheimer | Noah Kaye | $190 | $179 | -21.8% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $145 | $150.86 | -40.3% | Oct 1, 2025 |
| Goldman Sachs | Analyst unavailable | $159 | $138.62 | -34.6% | Sep 29, 2025 |
| Oppenheimer | Noah Kaye | $151 | $145.6 | -37.8% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $128 | $144.17 | -47.3% | Jul 31, 2025 |
| Mizuho Securities | Brett Linzey | $150 | $124.21 | -38.3% | Jul 16, 2025 |
| Wolfe Research | Nigel Coe | $155 | $120.72 | -36.2% | Jul 10, 2025 |
| UBS | Amit Mehrotra | $155 | $71.46 | -36.2% | Nov 13, 2024 |
| Cowen & Co. | Lance Vitanza | $115 | $110.03 | -52.7% | Oct 24, 2024 |
| Mizuho Securities | Brett Linzey | $125 | $109.72 | -48.5% | Oct 24, 2024 |
| Oppenheimer | Noah Kaye | $121 | $108.36 | -50.2% | Oct 24, 2024 |
| Evercore ISI | Amit Daryanani | $135 | $108.36 | -44.4% | Oct 23, 2024 |
| Cowen & Co. | Michael Elias | $93 | $95.98 | -61.7% | Sep 23, 2024 |
| Bank of America Securities | Andrew Obin | $115 | $76.99 | -52.7% | Sep 3, 2024 |
| Mizuho Securities | Brett Linzey | $92 | $69.27 | -62.1% | Aug 7, 2024 |
| Evercore ISI | Amit Daryanani | $105 | $95.31 | -56.8% | Jun 14, 2024 |
| Oppenheimer | Noah Kaye | $98 | $84.57 | -59.7% | Apr 25, 2024 |
| Wolfe Research | Nigel Coe | $97 | $85.34 | -60.1% | Apr 8, 2024 |
| Oppenheimer | Noah Kaye | $96 | $80.69 | -60.5% | Apr 4, 2024 |
| Wolfe Research | Nigel Coe | $94 | $81.01 | -61.3% | Mar 28, 2024 |
| Evercore ISI | Amit Daryanani | $80 | $73.37 | -67.1% | Mar 13, 2024 |
| Citigroup | Analyst unavailable | $18 | $13.64 | -92.6% | Dec 9, 2022 |
| Cowen & Co. | Lance Vitanza | $20 | $14.79 | -91.8% | Oct 27, 2022 |
| Mizuho Securities | Brett Linzey | $10 | $11.9 | -95.9% | Oct 4, 2022 |
| Goldman Sachs | Analyst unavailable | $17 | $12.65 | -93.0% | Aug 4, 2022 |
| Deutsche Bank | Analyst unavailable | $15 | $8.46 | -93.8% | Jul 13, 2022 |
| Goldman Sachs | Analyst unavailable | $15 | $10.99 | -93.8% | Jun 1, 2022 |
Track every rating change on VRT the moment it posts. Free to start.
Start freeGet the VRT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.